We are live on ! Find out more
Parnassus Investments

Parnassus Investments Portfolio holdings

AUM $37.4B
1-Year Est. Return 35.42%
This Fund
S&P 500
This Quarter Est. Return
+11.46%
1 Year Est. Return
+35.42%
3 Year Est. Return
+106.24%
5 Year Est. Return
+128.96%
10 Year Est. Return
+492.3%
AUM
$40.3B
AUM Growth
+$1.83B
Cap. Flow
-$1.8B
Cap. Flow %
-4.48%
Top 10 Hldgs %
30.76%
Holding
149
New
21
Increased
29
Reduced
58
Closed
12

Top Buys

Rank Stock Value
1
CRM icon
Salesforce
CRM
+$878M
2
BAC icon
Bank of America
BAC
+$864M
3
SYY icon
Sysco
SYY
+$624M
4
DHI icon
D.R. Horton
DHI
+$537M
5
AMAT icon
Applied Materials
AMAT
+$324M

Top Sells

Rank Stock Value
1
CMCSA icon
Comcast
CMCSA
+$866M
2
BDX icon
Becton Dickinson
BDX
+$599M
3
CSGP icon
CoStar Group
CSGP
+$499M
4
VZ icon
Verizon
VZ
+$492M
5
CME icon
CME Group
CME
+$338M

Sector Composition

Rank Sector Weight
1 Technology 26.04%
2 Financials 17.73%
3 Industrials 13.89%
4 Healthcare 13.3%
5 Consumer Staples 8.78%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BNY
76
Bank of New York Mellon
BNY
$111B
$111M 0.28%
2,444,145
CMI icon
77
Cummins
CMI
$78.5B
$110M 0.27%
455,464
BURL icon
78
Burlington
BURL
$17.4B
$109M 0.27%
535,924
SPG icon
79
Simon Property Group
SPG
$69.6B
$107M 0.27%
913,815
PNR icon
80
Pentair
PNR
$9.74B
$103M 0.26%
2,296,917
ALGN icon
81
Align Technology
ALGN
$11.2B
$98.3M 0.24%
466,281
+421,598
+944% +$84.4M
FDX icon
82
FedEx
FDX
$78.6B
$95.5M 0.24%
551,180
DOX icon
83
Amdocs
DOX
$6.61B
$95.3M 0.24%
1,048,646
AXP icon
84
American Express
AXP
$226B
$94.9M 0.24%
642,639
TGT icon
85
Target
TGT
$74.3B
$93.9M 0.23%
+630,045
New +$98.8M
ACN icon
86
Accenture
ACN
$117B
$92.5M 0.23%
346,720
+115,466
+50% +$31.9M
UNP icon
87
Union Pacific
UNP
$183B
$90.4M 0.22%
436,475
-1,362,785
-76% -$280M
BIIB icon
88
Biogen
BIIB
$32.3B
$84.7M 0.21%
305,808
-41,943
-12% -$11.8M
LRCX icon
89
Lam Research
LRCX
$392B
$79.5M 0.2%
+1,891,700
New +$79.1M
SNPS icon
90
Synopsys
SNPS
$85.9B
$78.6M 0.2%
246,131
-10,871
-4% -$3.4M
VRTX icon
91
Vertex Pharmaceuticals
VRTX
$138B
$69.4M 0.17%
240,281
-21,686
-8% -$6.61M
C icon
92
Citigroup
C
$224B
$68M 0.17%
+1,502,553
New +$68.3M
COF icon
93
Capital One
COF
$134B
$65.1M 0.16%
700,000
PAYX icon
94
Paychex
PAYX
$45.4B
$64.2M 0.16%
555,898
GWW icon
95
W.W. Grainger
GWW
$61.6B
$64.1M 0.16%
115,186
-39,946
-26% -$22.5M
ARE icon
96
Alexandria Real Estate Equities
ARE
$9.03B
$62.9M 0.16%
431,695
LEVI icon
97
Levi Strauss
LEVI
$8.26B
$53.8M 0.13%
3,467,865
-501,954
-13% -$7.8M
GAP
98
The Gap Inc
GAP
$8.48B
$53.3M 0.13%
4,729,419
-338,349
-7% -$4.05M
IFF icon
99
International Flavors & Fragrances
IFF
$22.4B
$50.6M 0.13%
+482,811
New +$47.5M
VEEV icon
100
Veeva Systems
VEEV
$46.1B
$30.3M 0.08%
188,042

Similar funds

Parnassus Investments's Q4 2022 Portfolio in Review

As of Q4 2022, Parnassus Investments held 149 positions worth $40.3B, up 4.8% from $38.4B the previous quarter. Its ten largest holdings account for 31% of the portfolio.

Parnassus Investments withdrew a net $1.8B in Q4 2022, closing 12 positions and reducing 58 holdings. Its most notable exit was Americold, an estimated $95.9M position sold in full.

By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 23% a quarter earlier, followed by Financials and Industrials.

Against the trend, Parnassus Investments opened a new position in Salesforce worth $798M.

  • Parnassus Investments's largest Q4 2022 buy was Salesforce: 6,018,220 shares worth $798M.
  • Parnassus Investments added most to Bank of America in Q4 2022, an estimated $864M increase.
  • Parnassus Investments's biggest Q4 2022 reduction was Comcast, cutting an estimated $866M.
  • Parnassus Investments fully exited Americold in Q4 2022, selling an estimated $95.9M.
  • Parnassus Investments's ten largest holdings make up 31% of its $40.3B portfolio in Q4 2022.
  • Parnassus Investments opened 21 new positions and closed 12 in Q4 2022.
  • Parnassus Investments's portfolio value rose 4.8% quarter-over-quarter to $40.3B.

Based on Parnassus Investments's 13F filing for Q4 2022, filed 30 Jan 2023.